SunTrust Starts Supernus Pharmaceuticals (SUPN) at Buy
Tweet
Share
E-mailGet Alerts SUPN Hot Sheet
Price: $29.95 +0.81%
Rating Summary:
8 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
8 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Supernus Pharmaceuticals (NASDAQ: SUPN) with a Buy rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Supernus Pharmaceuticals click here. For more ratings news on Supernus Pharmaceuticals click here.
Shares of Supernus Pharmaceuticals closed at $16.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loop Capital Starts MongoDB (MDB) at Buy, '2H Ramp Ahead'
- William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
- HSBC Starts Auna SA (AUNA) at Buy, 'Just what the doctor prescribed'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
